Indeed, most of the papers reporting IHC analyses of ADAM17 expression in tumor tissues employed an evaluation method based on a semiquantitative weighted histoscore, which combines staining intensity and percent of positive cells. This evidence concerns the gene ADAM17 and neoplasm.